Drug Profile
Research programme: NK cell therapeutics - Fate Therapeutics/University of California
Alternative Names: FT 519; iPSC-CAR-NK; NK-CAR + IL-15RFLatest Information Update: 15 Dec 2022
Price :
$50
*
At a glance
- Originator Fate Therapeutics; University of California, San Diego
- Class Gene therapies; Immunotherapies; Natural killer cell therapies
- Mechanism of Action Immunologic cytotoxicity; Natural killer cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cancer